LOADING
Comparing Salesforce Inc (CRM) and Pfizer Inc (PFE) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | CRM | PFE |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $180.7B | $151.1B |
| P/E Ratio | 24.7 | 19.5 |
| Forward P/E | 15.2 | 9.0 |
| PEG Ratio | 0.94 | 13.77 |
| EPS | $7.81 | $1.36 |
| Revenue Growth (YoY) | 12.1% | -1.2% |
| Profit Margin | 18.0% | 12.4% |
| Return on Equity | 12.4% | 8.9% |
| Dividend Yield | 0.84% | 6.40% |
| Beta | 1.31 | 0.41 |
| 52-Week High | $294.59 | $27.94 |
| 52-Week Low | $174.57 | $19.50 |
| Volume | -- | -- |
Salesforce Inc is the larger company by market capitalization. Pfizer Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Salesforce Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.